View Item 

Show simple item record

Methodological issues in radiation dose–volume outcome analyses: Summary of a joint AAPM/NIH workshop
dc.contributor.authorDeasy, Joseph O.
dc.contributor.authorNiemierko, Andrzej
dc.contributor.authorHerbert, Donald
dc.contributor.authorYan, Di
dc.contributor.authorJackson, Andrew
dc.contributor.authorTen Haken, Randall K.
dc.contributor.authorLanger, Mark
dc.contributor.authorSapareto, Steve
dc.date.accessioned2017-01-06T20:50:15Z
dc.date.available2017-01-06T20:50:15Z
dc.date.issued2002-09
dc.identifier.citationDeasy, Joseph O.; Niemierko, Andrzej; Herbert, Donald; Yan, Di; Jackson, Andrew; Ten Haken, Randall K.; Langer, Mark; Sapareto, Steve (2002). "Methodological issues in radiation dose–volume outcome analyses: Summary of a joint AAPM/NIH workshop." Medical Physics 29(9): 2109-2127.
dc.identifier.issn0094-2405
dc.identifier.issn2473-4209
dc.identifier.urihttps://hdl.handle.net/2027.42/135063
dc.publisherWiley Periodicals, Inc.
dc.publisherAmerican Association of Physicists in Medicine
dc.subject.otherImage motion analysis
dc.subject.otherLiver
dc.subject.otherMedical treatment planning
dc.subject.otherAnatomy
dc.subject.otherliver
dc.subject.otheroutcomes analysis
dc.subject.otherTCP
dc.subject.otherNTCP
dc.subject.othervolume effects
dc.subject.otherTreatment strategy
dc.subject.otherGeneral theory and mathematical aspects
dc.subject.otherprobability
dc.subject.otherlung
dc.subject.otherradiation therapy
dc.subject.otherphysiological models
dc.subject.otherdosimetry
dc.subject.otherDosimetry
dc.subject.otherNumerical modeling
dc.subject.otherCancer
dc.subject.otherData analysis
dc.subject.otherPhysicists
dc.subject.otherLungs
dc.titleMethodological issues in radiation dose–volume outcome analyses: Summary of a joint AAPM/NIH workshop
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor, Michigan 48109
dc.contributor.affiliationotherWilliam Beaumont Hospital, Royal Oak, Michigan 48073
dc.contributor.affiliationotherMemorial Sloan Kettering Cancer Center, New York, New York 10021
dc.contributor.affiliationotherCollege of Medicine, University of South Alabama, Mobile Alabama 36617
dc.contributor.affiliationotherGood Samaritan Regional Medical Center, Phoenix, Arizona 85006
dc.contributor.affiliationotherIndiana University, Indianapolis, Indiana 46202
dc.contributor.affiliationotherMassachusetts General Hospital & Harvard Medical School, Boston, Massachusetts 02114
dc.contributor.affiliationotherWashington University School of Medicine, St. Louis, Missouri 63110
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135063/1/mp1473.pdf
dc.identifier.doi10.1118/1.1501473
dc.identifier.sourceMedical Physics
dc.identifier.citedreferenceJ. M. Balter, R. K. Ten Haken, T. S. Lawrence, K. L. Lam, and J. R. Robertson, “ Uncertainties in CT‐based treatment plans due to patient breathing,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 36, 167 – 174 ( 1996 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. Jackson, M. W. Skwarchuk, and S. Levegrun, “Volume effects in external beam treatments of prostate cancer” (extended abstract), in ( Proceedings of the 5th International Symposium on 3D Conformal Radiation Therapy and Brachytherapy, edited by H. I. Amols and H. J. Zelefsky, Memorial Sloan–Kettering Cancer Center, New York, NY, 1–3 June 2000.
dc.identifier.citedreferenceJ. D. Fenwick, V. S. Khoo, A. E. Nahum, B. Sanchez‐Nieto, and D. P. Dearnaley, “ Correlations between dose–surface histograms and the incidence of long‐term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 49, 473 – 480 ( 2001 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceL. J. Boersma, E. M. Damen R. W. de Boer, S. H. Muller, R. A. Valdes Olmos, C. A. Hoefnagel, C. M. Roos, N. van Zandwijk, and J. V. Lebesque, “ A new method to determine dose‐effect relations for local lung‐function changes using correlated SPECT and CT data,” Radiother. Oncol. RAONDT --> 29, 110 – 116 ( 1993 ). RAONDT --> 0167‐8140
dc.identifier.citedreferenceL. B. Marks, M. T. Munley, D. P. Spencer, G. W. Sherouse, G. C. Bentel, J. Hoppenworth, M. Chew, R. J. Jaszczak, R. E. Coleman, and L. R. Prosnitz, “ Quantification of radiation‐induced regional lung injury with perfusion imaging,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 38, 399 – 409 ( 1997 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceL. B. Marks, D. Hollis, M. Munley, G. Bentel M. Garipagaoglu, M. Fan, J. Poulson, R. Clough, G. Sibley, R. E. Coleman, and R. Jaszczak, “ The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests,” Can. Mineral. CAMIA6 --> 88, 2135 – 2141 ( 2000 ). CAMIA6 --> 0008‐4476
dc.identifier.citedreferenceY. Seppenwoolde, S. H. Muller, J. C. Theuws, P. Baas, J. S. Belderbos, L. J. Boersma, and J. V. Lebesque, “ Radiation dose‐effect relations and local recovery in perfusion for patients with non‐small‐cell lung cancer,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 47, 681 – 690 ( 2000 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. G. Armstrong, M. J. Zelefsky, S. A. Leibel, C. Burman, C. Han, L. B. Harrison, G. J. Kutcher, and Z. Y. Fuks, “ Strategy for dose escalation using 3‐dimensional conformal radiation therapy for lung cancer,” Ann. Oncol. 6, 693 – 697 ( 1995 ). 0923‐7534
dc.identifier.citedreferenceL. A. Dawson, C. McGinn, D. Normolle, R. K. Ten Haken, W. Ensminger, and T. S. Lawrence, “ Escalated focal liver radiation and hepatic artery fluorodeoxyuridine for unresectable liver malignancies,” J. Clin. Oncol. JCONDN --> 18, 2210 – 2218 ( 2000 ). JCONDN --> 0732‐183X
dc.identifier.citedreferenceL. A. Dawson, R. K. Ten Haken, and T. S. Lawrence, “ Partial irradiation of the liver,” Semin Radiat. Oncol. 11, 234 – 239 ( 2001 ). 1053‐4296
dc.identifier.citedreferenceM. V. Graham, J. A. Purdy, B. Emami, J. W. Matthews, and W. B. Harms, “ Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 33, 993 – 1000 ( 1995 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. A. Hayman, M. K. Martel, R. K. Ten Haken, D. P. Normolle, R. F. Todd III, J. F. Littles, M. A. Sullivan, P. W. Possert, A. T. Turrisi, and A. S. Lichter, “ Dose escalation in non‐small cell lung cancer using 3‐dimensional conformal radiation therapy: update of a phase I trial,” J. Clin. Oncol. JCONDN --> 19, 127 – 136 ( 2001 ). JCONDN --> 0732‐183X
dc.identifier.citedreferenceB. L. Kwa, J. V. Lebesque, J. C. Theuws, L. B. Marks, M. T. Munley, G. Bentel, D. Oetzel, U. Spahn, M. V. Graham, R. E. Drzymala, J. A. Purdy, A. S. Lichter, M. K. Martel, and R. K. Ten Haken, “ Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 42, 1 – 9 ( 1998 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceL. B. Marks, M. Fan, R. Clough, M. Munley, G. Bentel, R. E. Coleman, R. Jaszczak, D. Hollis, and M. Anscher, “ Radiation‐induced pulmonary injury: symptomatic versus subclinical endpoints,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 76, 469 – 475 ( 2000 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceM. K. Martel, Ten Haken, M. B. Hazuka, A. T. Turrisi, B. A. Fraass, and A. S. Lichter, “ Dose–volume histogram and 3‐D treatment planning evaluation of patients with pneumonitis,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 28, 575 – 581 ( 1994 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceC. J. McGinn, R. K. Ten Haken, W. D. Ensminger, S. Walker, S. Wang, and T. S. Lawrence, “ The treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model,” J. Clin. Oncol. JCONDN --> 16, 2246 – 2252 ( 1998 ). JCONDN --> 0732‐183X
dc.identifier.citedreferenceD. Oetzel, P. Schraube, F. Hensley, G. Sroka‐Perez, M. Menke, and M. Flentje, “ Estimation of pneumonitis risk in three‐dimensional treatment planning using dose‐volume histogram analysis,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 33, 455 – 460 ( 1995 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. M. Robertson, R. K. Ten Haken, A. T. Turrisi, M. B. Hazuka, M. K. Martel, J. F. Littles, F. J. Martinez, I. Francis, L. Quint, and A. S. Lichter, “ Dose escalation for non‐small cell lung cancer using conformal radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 37, 1079 – 1085 ( 1997 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. Jackson, C. C. Ling, C. M. Burman, E. S. Venkatraman, J. Bass, A. Raben, S. A. Leibel, and Z. Fuks, “ A conformal dose escalation protocol for the treatment of tumors in the lung or other normal tissues with parallel architecture,” Med. Phys. MPHYA6 --> 23, 1495 ( 1996 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceR. K. Ten Haken, M. K. Martel, M. L. Kessler, M. B. Hazuka, T. S. Lawrence, J. M. Robertson, A. T. Turrisi, and A. S. Lichter, “ Use of Veff and iso‐NTCP in the implementation of dose escalation protocols,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 27, 689 – 695 ( 1993 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. Jackson, R. K. Ten Haken, J. M. Robertson, M. L. Kessler, G. J. Kutcher, and T. S. Lawrence, “ Analysis of clinical complication data for radiation hepatitis using a parallel architecture model,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 31, 883 – 891 ( 1995 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceS. A. Roberts and J. H. Hendry, “ The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum‐likelihood analysis of a collection of worldwide tumour‐control data,” Radiother. Oncol. RAONDT --> 29, 69 – 74 ( 1993 ). RAONDT --> 0167‐8140
dc.identifier.citedreferenceR. K. Ten Haken, T. S. Lawrence, D. L. McShan, R. J. Tesser, B. A. Fraass, and A. S. Lichter, “ Technical considerations in the use of 3‐D beams in the abdomen,” Radiother. Oncol. RAONDT --> 22, 19 – 28 ( 1991 ). RAONDT --> 0167‐8140
dc.identifier.citedreferenceT. S. Lawrence, R. J. Tesser, and R. K. Ten Haken, “ An application of dose volume histograms to treatment of intrahepatic malignancies with radiation,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 19, 1041 – 1047 ( 1990 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceT. S. Lawrence, L. M. Dworzanin, S. C. Walker‐Andrews, J. C. Andrews, R. K. Ten Haken, I. S. Wollner, A. S. Lichter, and W. D. Ensminger, “ Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 20, 555 – 561 ( 1991 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. T. Lyman, “ Complication probability as assessed from dose volume histograms,” Radiat. Res. RAREAE --> 104, S13 – S19 ( 1985 ). RAREAE --> 0033‐7587
dc.identifier.citedreferenceT. S. Lawrence, R. K. Ten Haken, M. L. Kessler, J. M. Robertson, J. T. Lyman, M. L. Lavigne, M. B. Brown, D. J. DuRoss, J. C. Andrews, W. D. Ensminger, and A. S. Lichter, “ The use of 3‐D dose volume analysis to predict radiation hepatitis,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 23, 781 – 788 ( 1992 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceG. J. Kutcher and C. Burman, “ Calculation of complication probability factors for nonuniform normal tissue irradiation: the effective volume method,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 16, 1623 – 1630 ( 1989 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. Hanley, M. M. Debois, D. Mah, G. S. Mageras, A. Raben, K. Rosenzweig, B. Mychalczak, L. H. Schwartz, P. J. Gloeggler, W. Lutz, C. C. Ling, S. A. Leibel, Z. Fuks, and G. J. Kutcher, “ Deep inspiration breath‐hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 45, 603 – 611 ( 1999 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. W. Wong, M. B. Sharpe, D. A. Jaffray, V. R. Kini, J. M. Robertson, J. S. Stromberg, and A. A. Martinez, “ The use of active breathing control (ABC) to reduce margin for breathing motion,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 44, 911 – 919 ( 1999 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. M. Balter, K. L. Lam, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, “ Improvement of CT‐based treatment planning models of abdominal targets using static exhale imaging,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 41, 939 – 943 ( 1998 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceR. K. Ten Haken, J. M. Balter, L. H. Marsh, J. M. Robertson, and T. L. Lawrence, “ Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 38, 613 – 617 ( 1997 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. E. Lujan, E. W. Larsen, J. M. Balter, and R. K. Ten Haken, “ A method for incorporating organ motion due to breathing into 3D dose calculations,” Med. Phys. MPHYA6 --> 26, 715 – 720 ( 1999 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceA. E. Lujan, R. K. Ten Haken, E. W. Larsen, and J. M. Balter, “ Quantization of setup uncertainties in 3D dose calculations,” Med. Phys. MPHYA6 --> 26, 2397 – 2402 ( 1999 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceN. Choi, J. E. Herndon II, J. Rosenmann, R. W. Carey, C. T. Chung, S. Bernard, L. Leone, S. Seagren, and M. Green, “ Phase I study to determine the maximum‐tolerated dose of radiation in standard daily and hyperfractioned‐accelerated twice‐daily radiation schedules with concurrent chemotherapy for limited stage small‐cell lung cancer,” J. Clin. Oncol. JCONDN --> 16, 3528 – 3537 ( 1998 ). JCONDN --> 0732‐183X
dc.identifier.citedreferenceC. R. Thomas, Jr., D. J. Giroux, K. J. Stelzer, J. B. Craig, L. R. Laufman, S. A. Taylor, J. W. Goodwin, J. J. Crowley, and R. B. Livingston, “ Concurrent cisplatin prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: A phase II study of the southwest oncology group (SWOG‐9229),” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 40, 1045 – 1047 ( 1998 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceM. V. Graham, “ Predicting radiation response,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 39, 561 – 562 ( 1997 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceL. Marks, M. T. Munley, G. C. Bentel, S.‐M. Zhou, D. Hollis, C. Scarfone, G. S. Sibley, F.‐M. Kong, R. Jirtle, R. Jaszczak, R. E. Coleman, V. Tapson, and M. Anscher, “ Physical and biological predictors of changes in whole lung function following thoracic irradiation,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 39, 563 – 570 ( 1997 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceM. V. Graham, J. A. Purdy, B. Emami, W. Harms, W. Bosch, M. A. Lockett, and C. A. Perez, “ Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non‐small cell lung cancer (NSCLC),” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 45, 323 – 329 ( 1999 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceM. Langer and P. Kijewski, “ CCRT for non‐small cell lung cancer: sensitivity of clinical gains to organ tolerance restrictions,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 22, 325 – 332 ( 1992 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceC. Ha, P. J. Kijewski, and M. P. Langer, “ Gain in target dose from using computer controlled radiotherapy (CCRT) in the treatment of nonsmall cell lung cancer. ” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 26, 335 – 356 ( 1991 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceM. V. Graham, J. A. Purdy, B. Emami, W. Harms, W. Bosch, M. A. Lockett, and C. A. Perez, “ Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non‐small lung cancer,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 45, 323 – 329 ( 1999 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceM. Langer, P. Kijewski, R. Brown, and C. Ha, “ The effect on minimum tumor dose of restricting target‐Dose inhomogeneity in optimized three‐dimensional treatment of lung cancer,” Radiother. Oncol. RAONDT --> 21, 245 – 256 ( 1991 ). RAONDT --> 0167‐8140
dc.identifier.citedreferenceM. V. Graham, J. W. Mathews, W. B. Harms, B. Emami, H. S. Glazer, and J. A. Purdy, “ Three‐dimensional radiation treatment planning study for patients with carcinoma of the lung,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 29, 1105 – 1117 ( 1994 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceH. H. Liu, I. I. Rosen, N. A. Janjan, and A. Pollack, “Treatment planning optimization based on response‐surface modeling of cost function versus multiple constraints,” CD‐ROM Proceedings of the World Congress on Medical Physics and Biomedical Engineering, 23–28 July 2000.
dc.identifier.citedreferenceM. Langer, V. Thai, and L. Papiez, “Sensitivity analysis of tolerance limits for dose‐escalation,” in Ref. 127.
dc.identifier.citedreferenceM. Langer, S. Morrill, and R. Lane, “ A test of the claim that plan rankings are determined by relative complication and tumor control probabilities,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 41, 451 – 457 ( 1998 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceG. B. Dantzig, in “Convex programming,” Linear Programming and Extensions (Princeton University Press, Princeton, NJ), Chap. 24, pp. 471–498.
dc.identifier.citedreferenceE. Fermi, “ The nucleus ” Phys. Today PHTOAD --> 5, 6 – 9 ( 1952 ). PHTOAD --> 0031‐9228
dc.identifier.citedreferenceE. J. Hall, in Radiobiology for the Radiologist, 4th ed. (Lippincott, Philadelphia, PA, 1994), p. 478.
dc.identifier.citedreferenceH. D. Thames and J. H. Hendry, in Fractionation in Radiotherapy (Taylor & Francis, New York, 1987), p. 297.
dc.identifier.citedreferenceA. Niemierko, “ Reporting and analyzing dose distributions: a concept of equivalent uniform dose. ” Med. Phys. MPHYA6 --> 24, 103 – 110 ( 1997 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceA. Terahara, A. Niemierko, M. Goitein, D. Finkelstein, E. Hug, N. Liebsch, D. O’Farrell, S. Lyons, and J. Munzenrider, “ Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 45, 351 – 358 ( 1999 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceQ. Wu, R. Mohan, and A. Niemierko, “IMRT optimization based on the generalized Equivalent Uniform Dose (EUD),” in ICCR 13, 2000, Heidelberg, Germany.
dc.identifier.citedreferenceH. R. Withers, J. M. Taylor, and B. Maciejewski, “ Treatment volume and tissue tolerance,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 14, 751 – 759 ( 1988 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. Niemierko and M. Goitein, “ Modeling of normal tissue response to radiation: the critical volume model,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 25, 135 – 145 ( 1993 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. Niemierko, “ A generalized concept of Equivalent Uniform Dose,” Med. Phys. MPHYA6 --> 26, 1100 ( 1999 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceG. J. Kutcher, C. Burman, L. Brewster, M. Goitein, and R. Mohan, “ Histogram reduction method for calculating complication probabilities for three‐dimensional treatment planning evaluations,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 21, 137 – 146 ( 1991 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. T. Lyman, “ Complication probability as assessed from dose–volume histograms,” Radiat. Res., Suppl. 8, S13 – S19 ( 1985 ).
dc.identifier.citedreferenceD. E. Herbert, “Quality assessment and improvement of dose‐response models: some effects of study weaknesses on study findings. C’est magnifique?” A Report of Task Group 1 of the AAPM Biological Effects Committee (Medical Physics Publishing, Madison, WI, 1993), AAPM Report No. 43.
dc.identifier.citedreferenceA. Niemierko, “ A unified model of tissue response to radiation,” Med. Phys. MPHYA6 --> 26, 1100 ( 1999 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceK. S. C. Chao, J. O. Deasy, J. Markman, J. Haynie, C. A. Perez, J. A. Purdy, and D. A. Low, “ A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity‐modulated or three‐dimensional radiation therapy: initial results,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 49, 907 – 916 ( 2001 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceG. E. P. Box, “Robustness in the strategy of scientific model building,” in Robustness in Statistics, edited by R. L. Launer and G. N. Wilkinson (Academic, New York, 1979), pp. 201–236.
dc.identifier.citedreferenceD. Herbert, “Quality assessment and improvement of dose response models: Some effects of study weaknesses on study findings. C’est magnifique?,” “Evaluation of Models for Dose‐Response in Radiation Oncology,” of the Biological Effects Committee, A Report of Task Group 1 (Medical Physics Publishing, Madison, WI, 1993), AAPM Report No. 43.
dc.identifier.citedreferenceL. Cohen, in Ref. 15, pp. i–iii.
dc.identifier.citedreferenceJ. F. Williamson, P. G. Goldschmidt, and T. Colton, “The quality of medical literature: An analysis of validation assessments,” in Medical Uses of Statistics, edited by J. C. Bailar, III and F. Mosteller, (NEJM Books. Waltham, MA, 1986), pp. 370–391.
dc.identifier.citedreferenceM. R. Chassin and R. W. Galvin, “ The urgent need to improve health care quality,” J. Am. Med. Assoc. JAMAAP --> 280, 1000 – 1004 ( 1998 ). JAMAAP --> 0098‐7484
dc.identifier.citedreferenceM. Hewett and J. Simone, in Ensuring Quality Cancer Care, Institute of Medicine/National Research Council (National Academic, Washington, DC, 1999).
dc.identifier.citedreferenceJ. E. Ware, “ The status of health assessment 1994,” Annu. Rev. Public Health 16, 327 – 354 ( 1995 ). 0163‐7525
dc.identifier.citedreferenceU.S. Congress Patient Outcome Research Act, 1989.
dc.identifier.citedreferenceF. Mosteller (personal communication, 1999).
dc.identifier.citedreferenceT. Chalmers, “ Problems induced by meta‐analysis,” Stat. Med. 10, 971 – 980 ( 1991 ). 0277‐6715
dc.identifier.citedreferenceNational Research Council, Combining Information. Statistical Issues and Opportunities for Research, Washington, DC, 1992.
dc.identifier.citedreferenceT. Chalmers, “ Meta‐analysis in clinical medicine,” Trans. Am. Clin. Climatol. Assoc. 99, 144 – 150 ( 1987 ). 0065‐7778
dc.identifier.citedreferenceL. Bero and D. Rennie, “ The Cochrane collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care,” J. Am. Med. Assoc. JAMAAP --> 274, 1935 – 1938 ( 1995 ). JAMAAP --> 0098‐7484
dc.identifier.citedreferenceC. Naylor, “ Gray zones of clinical practice: Some limits to evidence‐based medicine,” Lancet LANCAO --> 345, 840 – 942 ( 1995 ). LANCAO --> 0140‐6736
dc.identifier.citedreferenceS. B. Thacker and R. L. Berkelman, “ Surveillance of medical technologies,” J. Public Health Policy 7, 363 – 377 ( 1986 ). 0197‐5897
dc.identifier.citedreferenceS. J. Senn, “ Falsificationism and clinical trials,” Stat. Med. 10, 1679 – 1692 ( 1991 ). 0277‐6715
dc.identifier.citedreferenceR. Brook, “ Using scientific information to improve quality of health care,” in Doing More Good Than Harm. The Evaluation of Health Care Interventions, edited by K. Warren and F. Mosteller, Ann. N.Y. Acad. Sci. ANYAA9 --> 703, 74 – 85 ( 1993b ). ANYAA9 --> 0077‐8923
dc.identifier.citedreferenceU.S. General Accounting Office, Cross Design Synthesis, GAO/OEND‐92‐18. Washington, DC, 1992.
dc.identifier.citedreferenceD. Herbert, “Response surfaces for binary events. An empirical basis for radiation oncology,” in Proceedings of the 6th International Conference on the Use of Computers in Radiation Therapy, edited by U. H. Rosenow (Gottingen University Press, Gottingen, Federal Republic of Germany, 1978), pp. 210–238.
dc.identifier.citedreferenceD. Herbert, “ An extreme value paradigm for the effect of size on target volume on end results in radiation oncology,” Med. Phys. MPHYA6 --> 10, 589 – 604 ( 1983 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceD. Herbert, “An empirical extreme value model of the volume effect in radiation oncology,” in Optimization of Cancer Radiotherapy, Proceedings of the 2nd International Conference on Dose, Time, and Fractionation in Radiation Oncology, edited by B. Paliwal, D. Herbert, and C. Orton (American Institute of Physics, New York, NY, 1984), pp. 381–401.
dc.identifier.citedreferenceG. E. P. Box, “The determination of optimum conditions,” in The Design and Analysis of Industrial Experiments, edited by O. Davies (Oliver and Boyd, London, 1967).
dc.identifier.citedreferenceD. Herbert, “ The bivariate probit model of uncomplicated control of tumor: A heuristic exposition of the methodology,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 39, 213 – 225 ( 1997 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceR. M. Califf, D. B. Pryor, and J. C. Greenfield, “ Beyond randomized clinical trials: Applying clinical experience in the treatment of patients with coronary artery disease,” Circulation CIRCAZ --> 74, 1191 – 1194 ( 1986 ). CIRCAZ --> 0009‐7322
dc.identifier.citedreferenceD. J. Hand, “ Date mining: Statistics and more. ” Am. Stat. ASTAAJ --> 52, 112 – 118 ( 1998 ). ASTAAJ --> 0003‐1305
dc.identifier.citedreferenceL. Glass, “ Nonlinear dynamics of physiological function and control,” Chaos CHAOEH --> 1, 247 – 250 ( 1991 ). CHAOEH --> 1054‐1500
dc.identifier.citedreferenceP. Anderson, “ More is different,” Science SCIEAS --> 177, 393 – 396 ( 1972 ). SCIEAS --> 0036‐8075
dc.identifier.citedreferenceD. Herbert, “Modeling the effectiveness of radiation treatment,” in Biomedical Uses of Radiation, edited by W. R. Hendee (Wiley‐VCH, New York, 1999), pp. 1227–1288.
dc.identifier.citedreferenceD. E. Herbert and D. J. Brenner, “ The use of the linear quadratic model in clinical radiation oncology can be defended on the basis of empirical evidence and theoretical argument,” Med. Phys. MPHYA6 --> 24, 1245 – 1248 ( 1997 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceD. Herbert, “Overview of nonlinear dynamical systems and complexity theory,” in Chaos and the Changing Nature of Science and Medicine: An Introduction, edited by D. Herbert (American Institute of Physics, New York, NY 1996), pp. 1–34.
dc.identifier.citedreferenceL. Thomas, Late Night Thoughts on Listening to Mahler’s Ninth Symphony (Viking Press, New York, 1983).
dc.identifier.citedreferenceM. Goitein, A. Niemierko, and P. Okunieff, “The probability of controlling an inhomogeneously irradiated tumour: a strategem for improving tumour control through partial tumour boosting,” presented at the 19th L H Gray Conference: Quantitative Imaging in Oncology, Newcastle, 1997.
dc.identifier.citedreferenceJ. O. Deasy, “Tumor control probability models for nonuniform dose distributions,” Proceedings of the 5th International Conference on Dose, Time and Fractionation in Radiation Oncology: Volume and Kinetics in Tumor Control and Normal Tissue Complications, Madison (Medical Physics Publishing, Madison, 1998), pp. 65–85 (also available from http://castor.wustl.edu/∼deasy ).
dc.identifier.citedreferenceA. T. Tome and J. F. Fowler, “ Selective boosting of tumor subvolumes,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 48, 593 – 599 ( 2000 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. O. Deasy, “ Partial tumor boosts: even more attractive than theory predicts,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 51, 279 – 280 ( 2001 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. E. Nahum and D. M. Tait, “Maximising local control by customising dose prescription for pelvic tumours,” in Advanced Radiation Therapy—Tumor Response Monitoring and Treatment Planning, edited by A. Breit (Springer‐Verlag, Heidelberg, 1992), pp. 425–431.
dc.identifier.citedreferenceA. Terahara, A. Niemierko, M. Goitein, D. Finkelstein, E. Hug, N. Liebsch, D. O’Farrell, S. Lyons, and J. Munzenrider, “ Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 45, 351 – 358 ( 1999 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceS. Levegrun, A. Jackson, M. J. Zelefsky, E. S. Venkatraman, M. W. Skwarchuk, W. Schlegel, Z. Fuks, S. A. Leibel, and C. C. Ling, “ Analysis of biopsy outcome after three‐dimensional conformal radiation therapy of prostate cancer using dose‐distribution variables and tumor control probability models,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 47, 1245 – 1260 ( 2000 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. O. Deasy, “Inter‐patient and Intra‐tumor radiosensitivity heterogeneity,” in Ref. 46, pp. 363–381.
dc.identifier.citedreferenceR. A. Britten, A. J. Evans, M. J. Allalunis‐Turner, A. J. Franko, and R. G. Pearcey, “ Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness,” Radiother. Oncol. RAONDT --> 39, 145 – 153 ( 1996 ). RAONDT --> 0167‐8140
dc.identifier.citedreferenceB. Efron and R. J. Tibshirani, An introduction to the Bootstrap (Chapman & Hall, New York, 1993).
dc.identifier.citedreferenceK. S. C. Chao, J. O. Deasy, J. Markman, J. Haynie, C. A. Perez, J. A. Purdy, and D. A. Low, “ A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity‐modulated or three‐dimensional radiation therapy: initial results,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 49, 907 – 916 ( 2001 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. O. Deasy, J. Markman, and K. S. C. Chao, “Uncertainties in outcome predictions for treatment planning,” Int. J. Radiat. Oncol., Biol., Phys. 49, 907–916 (2001).
dc.identifier.citedreferenceJ. Markman, J. O. Deasy, C. K. Chao, and D. Low, “Bioeffect modeling of nonuniform dose distributions for paired organs,” Proceedings of the World Congress on Medical Physics and Bioengineering, Chicago, IL, 2000 (CD‐ROM).
dc.identifier.citedreferenceJ. H. Zar, Biostatistical Analysis (Prentice–Hall, Englewood Cliffs, NJ, 1984).
dc.identifier.citedreferenceL. B. Marks et al., “ The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 26, 659 – 668 ( 1993 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. F. Fowler, “ Is repair of DNA strand break damage from ionizing radiation second‐order rather than first‐order? A simple explanation of apparently multiexponential repair,” Radiat. Res. RAREAE --> 152, 124 – 136 ( 1999 ). RAREAE --> 0033‐7587
dc.identifier.citedreferenceP. A. Canney and W. T. Millar, “ Biphasic cellular repair and implications for multiple field radiotherapy treatments,” Br. J. Radiol. BJRAAP --> 70, 817 – 822 ( 1997 ). BJRAAP --> 0007‐1285
dc.identifier.citedreferenceJ. O. Deasy, J. F. Fowler, J. L. Roti Roti, and D. A. Low, “ Dose‐rate effects in intensity modulated radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 51, 400 – 401 ( 2001 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceJ. Bijhold, “ Three‐dimensional verification of patient placement during radiotherapy using portal images,” Med. Phys. MPHYA6 --> 20, 347 – 356 ( 1993 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceD. Yan, D. Jaffray, and J. Won, “ A model to accumulate the fractionated dose in a deforming organ,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 44, 665 – 675 ( 1999 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceW. Lu, “A generalization of adaptive radiotherapy and the registration of deformable dose distribution,” XIIIth International Conference on The Use of Computers in Radiotherapy, Heidelberg, Germany, 2000.
dc.identifier.citedreferenceJ. Williamson, “A deformable template approach to registration of serial CT studies for dose planning in intracavitary brachytherapy,” in Ref. 65.
dc.identifier.citedreferenceJ. Bijhold, J. V. Lebesque, A. M. Augustinus Hart, and R. E. Vijlbrirf, “ Maximizing setup accuracy using portal images as applied to a conformal boost technique for prostatic cancer,” Radiother. Oncol. RAONDT --> 24, 261 – 271 ( 1992 ). RAONDT --> 0167‐8140
dc.identifier.citedreferenceD. Yan, D. Lockman, D. Brabbins, L. Tyburski, and A. Martinez, “ An off‐line strategy for constructing a patient‐specific planning target volume for image guided adaptive radiotherapy of prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 48, 289 – 302 ( 2000 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceD. Yan and D. Lockman, “ Organ/patient positioning variation in external beam radiotherapy and its effects,” Med. Phys. MPHYA6 --> 28, 593 – 602 ( 2001 ). MPHYA6 --> 0094‐2405
dc.identifier.citedreferenceJ. Leong, “ Implementation of random positioning error in computerized radiation treatment planning systems as a result of fractionation,” Phys. Med. Biol. PHMBA7 --> 32, 327 – 334 ( 1987 ). PHMBA7 --> 0031‐9155
dc.identifier.citedreferenceJ. F. Fowler, “ The linear‐quadratic formula and progress in fractionated radiotherapy,” Br. J. Radiol. BJRAAP --> 62, 679 – 694 ( 1989 ). BJRAAP --> 0007‐1285
dc.identifier.citedreferenceG. W. Barensden, “ Dose fractionation, dose rate and iso‐effect relationships for normal tissue response,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 8, 1981 – 1997 ( 1982 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceB. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, “ Tolerance of normal tissue to theraputic irradiation,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 21, 109 – 122 ( 1991 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceH. Mameghan, R. Fisher, J. Mameghan, W. H. Watt, and A. Tynan, “ Bowel complications after radiotherapy for carcinoma of the prostate: The volume effect,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 18, 315 – 320 ( 1990 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceD. P. Dearnaley, V. S. Khoo, A. R. Norman, L. Meyer, A. Nahum, D. Tait, J. Yarnold, and A. Howwich, “ Comparison of radiation side‐effects of conformal and conventional radiotherapy in prostate cancer: a randomised clinical trial,” Lancet LANCAO --> 353, 267 – 272 ( 1999 ). LANCAO --> 0140‐6736
dc.identifier.citedreferenceV. A. Benk, J. A. Adams, W. U. Shipley, M. M. Urie, P. L. McManus, J. T. Efrid, C. G. Willet, and M. Goitein, “ Late rectal bleeding following combined x‐ray and proton high dose irradiation for patients with stages T3–T4 prostate carcinoma,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 26, 551 – 557 ( 1993 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceC. A. Lawton et al., “ Long‐term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 21, 935 – 939 ( 1991 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. C. Hartford, A. Niemierko, J. A. Adams, M. M. Urie, and W. U. Shipley, “ Conformal irradiation of the prostate: estimating long term rectal bleeding using dose–volume histograms,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 36, 721 – 730 ( 1996 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceT. E. Schultheiss, W. R. Lee, M. A. Hunt, A. L. Hanlon, R. S. Peter, and G. E. Hanks, “ Late GI and GU complications in the treatment of prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 37, 3 – 11 ( 1997 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceL. J. Boersma, M. van den Brink, A. M. Bruce, T. Shouman, L. Gras, A. te Velde, and J. V. Lebesque, “ Estimation of the incidence of late bladder and rectum complications after high dose (70–78 Gy) conformal radiotherapy for prostate cancer, using dose–volume histograms,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 41, 83 – 92 ( 1998 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceM. W. Skwarchuk, A. Jackson, M. J. Zelefsky, E. S. Venkatraman, D. M. Cowen, S. Levegrun, C. M. Burman, Z. Fuks, S. A. Leibel, and C. C. Ling, “ Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose‐response,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 47, 103 – 113 ( 2000 ). IOBPD3 --> 0360‐3016
dc.identifier.citedreferenceA. Jackson, M. W. Skwarchuk, M. J. Zelefsky, D. M. Cowen, E. S. Venkatraman, S. Levegrun, C. M. Burman, G. J. Kutcher, Z. Fuks, S. A. Leibel, and C. C. Ling, “ Late rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose volume histograms,” Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 --> 49, 685 – 698 ( 2001 ). IOBPD3 --> 0360‐3016
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
mp1473.pdf
Size:
270.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.